Oscar Health, Inc.
NYSE:OSCR
17.65 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,219.341 | 2,142.305 | 1,431.658 | 1,439.961 | 1,522.124 | 1,468.15 | 1,037.66 | 40.086 | 1,058.335 | 1,011.076 | 520.327 | 462.193 | 549.747 | 369.388 | 187.629 | 133.309 | 145.574 | 123.129 |
| Cost of Revenue
| 0 | -0 | 0.976 | -0.03 | 0.589 | -1.535 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -19.306 | 0 | 0 | 0 | 0 |
| Gross Profit
| 2,219.341 | 2,142.305 | 1,430.682 | 1,439.991 | 1,521.535 | 1,469.685 | 1,037.66 | 40.086 | 1,058.335 | 1,011.076 | 520.327 | 462.193 | 549.747 | 388.694 | 187.629 | 133.309 | 145.574 | 123.129 |
| Gross Profit Ratio
| 1 | 1 | 0.999 | 1 | 1 | 1.001 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1.052 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 435.144 | 394.696 | 85.61 | 75.503 | 76.453 | 102.15 | 75.808 | 78.557 | 80.754 | 74.664 | 89.338 | 61.267 | 50.911 | 63.062 | 62.276 | 36.546 | 35.994 | 31.839 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 435.144 | 394.696 | 85.61 | 75.503 | 76.453 | 102.15 | 75.808 | 78.557 | 80.754 | 74.664 | 89.338 | 61.267 | 50.911 | 63.062 | 62.276 | 36.546 | 35.994 | 31.839 |
| Other Expenses
| -442.807 | -401.973 | 1,491.525 | 1,422.732 | 1,451.611 | 1,392.9 | 2,183.092 | 1,092.242 | -149.503 | -1,155.154 | 602.984 | 595.656 | 550.621 | 368.857 | -436.742 | -249.985 | -220.919 | -250.916 |
| Operating Expenses
| 442.807 | 401.973 | 1,577.135 | 1,498.235 | 1,528.064 | 1,495.05 | 2,258.9 | 1,170.799 | 1,127.549 | -1,080.49 | 692.322 | 656.923 | 601.532 | 431.919 | -374.466 | -213.439 | -184.925 | -219.077 |
| Operating Income
| 67.812 | 185.558 | -145.477 | -58.244 | -6.529 | -30.304 | -220.626 | -185.172 | -106.487 | -69.414 | -198.636 | -212.944 | -72.251 | -62.531 | -186.837 | -80.13 | -39.351 | -95.948 |
| Operating Income Ratio
| 0.031 | 0.087 | -0.102 | -0.04 | -0.004 | -0.021 | -0.213 | -4.619 | -0.101 | -0.069 | -0.382 | -0.461 | -0.131 | -0.169 | -0.996 | -0.601 | -0.27 | -0.779 |
| Total Other Income Expenses Net
| 60.949 | 178.478 | -5.167 | -6.544 | -7.732 | -7.303 | -6.649 | -9.99 | -5.348 | -6.389 | 0.783 | -0.398 | -0.228 | -23.875 | -3.514 | 0 | 0 | 0 |
| Income Before Tax
| 60.949 | 178.478 | -150.644 | -64.788 | -14.261 | -37.607 | -227.275 | -195.162 | -111.835 | -75.803 | -197.853 | -213.342 | -72.479 | -86.406 | -190.351 | -80.13 | -39.351 | -95.948 |
| Income Before Tax Ratio
| 0.027 | 0.083 | -0.105 | -0.045 | -0.009 | -0.026 | -0.219 | -4.869 | -0.106 | -0.075 | -0.38 | -0.462 | -0.132 | -0.234 | -1.015 | -0.601 | -0.27 | -0.779 |
| Income Tax Expense
| 4.637 | 0.996 | -0.806 | 0.915 | 1.164 | 2.021 | -0.715 | -1.615 | 0.29 | 1.517 | -0.111 | -0.597 | 0.589 | 0.965 | -0.481 | -0.998 | 1.593 | 0.931 |
| Net Income
| 56.207 | 177.368 | -150.03 | -65.398 | -15.528 | -39.628 | -226.56 | -193.547 | -112.164 | -77.32 | -198.922 | -212.745 | -73.068 | -87.371 | -189.87 | -79.132 | -40.944 | -96.879 |
| Net Income Ratio
| 0.025 | 0.083 | -0.105 | -0.045 | -0.01 | -0.027 | -0.218 | -4.828 | -0.106 | -0.076 | -0.382 | -0.46 | -0.133 | -0.237 | -1.012 | -0.594 | -0.281 | -0.787 |
| EPS
| 0.24 | 0.77 | -0.66 | -0.29 | -0.071 | -0.18 | -1.05 | -0.91 | -0.53 | -0.37 | -0.95 | -1.02 | -0.35 | -0.98 | -0.96 | -2.7 | -1.4 | -3.31 |
| EPS Diluted
| 0.2 | 0.6 | -0.66 | -0.29 | -0.071 | -0.18 | -1.05 | -0.91 | -0.53 | -0.37 | -0.95 | -1.02 | -0.35 | -0.98 | -0.93 | -0.39 | -0.2 | -0.48 |
| EBITDA
| -6.968 | -7.194 | -145.477 | -58.244 | -6.529 | -25.365 | -216.891 | -181.114 | -5.387 | -65.615 | -194.666 | -209.299 | -68.664 | -79.306 | -183.542 | -77.205 | -36.83 | -93.404 |
| EBITDA Ratio
| -0.003 | -0.003 | -0.102 | -0.04 | -0.004 | -0.017 | -0.209 | -4.518 | -0.005 | -0.065 | -0.374 | -0.453 | -0.125 | -0.215 | -0.978 | -0.579 | -0.253 | -0.759 |